GRCU Huge News - Green Cures & Botanical Distribu
Post# of 72741
Posted On: 05/29/2014 9:36:56 AM
GRCU Huge News - Green Cures & Botanical Distribution Inc., announces the introduction of its CBD Capsules beginning in June 2014, and provides corporate update. PR Newswire "Press Releases US - English"
WINNETKA, Calif. , May 29, 2014 /PRNewswire/ -- Green Cures & Botanical Distribution, Inc. (OTC Pink: GRCU) ("Green Cures"
announced today that it will introduce its first CDB derived product to the public during the month of June 2014 , and also provided a corporate update.
Green Cures is pleased to announce the addition of CBD Capsules to its line of products in the upcoming weeks. Green Cures' set of 30 CBD Capsules will initially contain 50 milligrams of Pure CBD-Hemp Oil per capsule. Green Cures' CBD Capsules do not contain controlled substances, as their low THC content falls within federal guidelines. Therefore, Green Cures will be able to market, distribute and sell its upcoming product online and through retailers across the nation. Cannabidiol (CBD) has been the subject of numerous scientific studies at several academic research centers in the United States and across the globe. It is the second most prominent ingredient found in the Cannabis plant, accounting for up to 40% of the plant's extract. According to published scientific and clinical studies, CBD may act in the form of an experimental model to improve a wide range of conditions, including epilepsy, arthritis, rheumatoid, diabetes, alcoholism, chronic pain, schizophrenia, antibiotic-resistant infections, and other neurological disorders.
Additionally, Management of Green Cures announced that Green Cures is exploring additional opportunities to expand its services and operations within the hemp and cannabis industry, particularly, in the field of agriculture. "Currently, in the United States , the demand for high quality raw material throughout the hemp industry and cannabis medicinal field outstrips the supply; therefore, we are exploring the possibility of being able to supply raw materials for our current and upcoming products, domestically and internationally," said Green Cures CEO Robert Calkin . At the present time, Green Cures plans to form its first subsidiary company, which will operate in the field of agriculture, as permitted by law. Furthermore, Green Cures is reviewing and has been in negotiations with several highly qualified individuals in the fields of horticulture and microbiology, with a view to their potentially joining the new subsidiary in the near future.
Green Cures is also pleased to announce that it has received an exclusive invitation to be part of the " International Cannabis Association " exposition scheduled for June 22, 2014 , in Las Vegas, Nevada , where Green Cures will proudly showcase its current and upcoming line of products and services available to the public, as of the date of that event.
In closing, the company will be providing additional updates as they become available.
About Green Cures & Botanical Distribution, Inc.
www.gcbdinc.com)Green Cures & Botanical Distribution Inc. (GRCU) operates a diverse portfolio of services and products within the botanical and medical cannabis industry, as permitted by law. The products includenutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty.In this rapidly growing industry of alternative care and medicinal products, GRCU also provides to the online community portals that supply with information and resources regarding the benefits of cannabis-derived products.
FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA . The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as "scheduled (future sense)" "intend(s)", "plan(s)" "expect(s)", "believe(s)" "will" "estimate(s)", "anticipate(s)", "expect(s)", "may", "would", "could" or "should" or, in each case, the negative thereof, other variations thereon, comparable terminology that implies anticipated future deliverables. The Company disclaims any obligation or intention to update any forward-looking statement for any reason.
SOURCE Green Cures & Botanical Distribution, Inc.
WINNETKA, Calif. , May 29, 2014 /PRNewswire/ -- Green Cures & Botanical Distribution, Inc. (OTC Pink: GRCU) ("Green Cures"
announced today that it will introduce its first CDB derived product to the public during the month of June 2014 , and also provided a corporate update. Green Cures is pleased to announce the addition of CBD Capsules to its line of products in the upcoming weeks. Green Cures' set of 30 CBD Capsules will initially contain 50 milligrams of Pure CBD-Hemp Oil per capsule. Green Cures' CBD Capsules do not contain controlled substances, as their low THC content falls within federal guidelines. Therefore, Green Cures will be able to market, distribute and sell its upcoming product online and through retailers across the nation. Cannabidiol (CBD) has been the subject of numerous scientific studies at several academic research centers in the United States and across the globe. It is the second most prominent ingredient found in the Cannabis plant, accounting for up to 40% of the plant's extract. According to published scientific and clinical studies, CBD may act in the form of an experimental model to improve a wide range of conditions, including epilepsy, arthritis, rheumatoid, diabetes, alcoholism, chronic pain, schizophrenia, antibiotic-resistant infections, and other neurological disorders.
Additionally, Management of Green Cures announced that Green Cures is exploring additional opportunities to expand its services and operations within the hemp and cannabis industry, particularly, in the field of agriculture. "Currently, in the United States , the demand for high quality raw material throughout the hemp industry and cannabis medicinal field outstrips the supply; therefore, we are exploring the possibility of being able to supply raw materials for our current and upcoming products, domestically and internationally," said Green Cures CEO Robert Calkin . At the present time, Green Cures plans to form its first subsidiary company, which will operate in the field of agriculture, as permitted by law. Furthermore, Green Cures is reviewing and has been in negotiations with several highly qualified individuals in the fields of horticulture and microbiology, with a view to their potentially joining the new subsidiary in the near future.
Green Cures is also pleased to announce that it has received an exclusive invitation to be part of the " International Cannabis Association " exposition scheduled for June 22, 2014 , in Las Vegas, Nevada , where Green Cures will proudly showcase its current and upcoming line of products and services available to the public, as of the date of that event.
In closing, the company will be providing additional updates as they become available.
About Green Cures & Botanical Distribution, Inc.
www.gcbdinc.com)Green Cures & Botanical Distribution Inc. (GRCU) operates a diverse portfolio of services and products within the botanical and medical cannabis industry, as permitted by law. The products includenutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty.In this rapidly growing industry of alternative care and medicinal products, GRCU also provides to the online community portals that supply with information and resources regarding the benefits of cannabis-derived products. FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA . The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as "scheduled (future sense)" "intend(s)", "plan(s)" "expect(s)", "believe(s)" "will" "estimate(s)", "anticipate(s)", "expect(s)", "may", "would", "could" or "should" or, in each case, the negative thereof, other variations thereon, comparable terminology that implies anticipated future deliverables. The Company disclaims any obligation or intention to update any forward-looking statement for any reason.
SOURCE Green Cures & Botanical Distribution, Inc.
(0)
(0)